TrianglePUBLICATIONS · 16116598
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 2005 Oct 1
- First author
- Larson RA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Larson RA
- type
- Author
- name
- Sievers EL
- type
- Author
- name
- Stadtmauer EA
- type
- Author
- name
- Löwenberg B
- type
- Author
- name
- Estey EH
- type
- Author
- name
- Dombret H
- type
- Author
- name
- Theobald M
- type
- Author
- name
- Voliotis D
- type
- Author
- name
- Bennett JM
- type
- Author
- name
- Richie M
- type
- Author
- name
- Leopold LH
- type
- Author
- name
- Berger MS
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Larson RA
- type
- Author
- name
- Sievers EL
- type
- Author
- name
- Stadtmauer EA
- type
- Author
- name
- Löwenberg B
- type
- Author
- name
- Estey EH
- type
- Author
- name
- Dombret H
- type
- Author
- name
- Theobald M
- type
- Author
- name
- Voliotis D
- type
- Author
- name
- Bennett JM
- type
- Author
- name
- Richie M
- type
- Author
- name
- Leopold LH
- type
- Author
- name
- Berger MS
- type
- Author
- bibliography ids
- nci-bib-306ca3c61aa11bf9895e5f1a
- book metadata
- content sha256
- 49706bcd047fa4667f88038bb3ccf24f5c1a837ab87cb8d928e94c8ae7710fc8
- document type
- citation
- dois
- 10.1002/cncr.21326
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:16116598
- immutable id
- pubmed:16116598@49706bcd047fa4667f88038bb3ccf24f5c1a837ab87cb8d928e94c8ae7710fc8
- journal
- abbreviation
- Cancer
- issn electronic
- Source null
- issn print
- 0008-543X
- issue
- 7
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 1442-52
- volume
- 104
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 16116598
- provenance
- batch id
- acd1a19ec1fd03e5b423
- provider
- NCBI PubMed ESummary
- record sha256
- 904bc852f3b926395f3055b45b654b95942824c1f9bae8a4e87e29237413be1f
- response sha256
- 06f2789b1faf1384eea463ec33b6ace6458084d0e39588df6f3b23cecac27647
- retrieved at
- 2026-09-09T23:46:01.895425+00:00
- publication date
- display
- 2005 Oct 1
- precision
- day
- year
- 2005
- publication types
- Comparative Study
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.
Preserved source evidence · Not medical advice